Close Menu

NEW YORK (GenomeWeb) – Illumina announced after the close of the market on Monday that a UK court has ruled that Ariosa Diagnostics infringed its patent covering a method for noninvasive prenatal testing.

The UK High Court of Justice, Chancery Division, Patents Court issued a judgment finding that Ariosa's Harmony cell-free, DNA-based NIPT infringes Illumina's European patent 1 524 321. The court also found the patent's claims were valid.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
10

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.